WS
ZVRA icon

Wedbush Securities’s Zevra Therapeutics ZVRA Stock Holding History

Wedbush Securities’s Portfolio ZVRA Stock Details ZVRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-7,747
Closed -$47K – 1023
2019
Q4 		$47K Buy
7,747
+1,658
+27% +$13.2K ﹤0.01% 966
2019
Q3 		$67K Buy
6,089
+5,363
+739% +$96.9K 0.01% 919
2019
Q2 		$20K Sell
726
-1,978
-73% -$49.7K ﹤0.01% 974
2019
Q1 		$72K Buy
+2,704
New +$99.5K 0.01% 876
2017
Q1 		– Sell
-1,250
Closed -$59K – 887
2016
Q4 		$59K Buy
1,250
+469
+60% +$28.8K 0.01% 771
2016
Q3 		$56K Buy
781
+62
+9% +$4.41K 0.01% 788
2016
Q2 		$46K Buy
+719
New +$118K 0.01% 734

Other funds holding ZVRA

DA
DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BBVA
Banco Bilbao Vizcaya Argentaria Madrid, Spain $14.3B AUM 26.23% 1-Year Est. Return
RFN
RDA Financial Network Akron, Iowa $459M AUM 24.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return